by Certifié Conforme | 5 May Tue | English
Highly experienced partners bringing 25+ years of leadership across top-tierlife-sciences investment fund, pharma and Biopharma companies, driving accelerated portfolio development With leadership experience at Blackstone Life Sciences (Deputy Chief Operating...
by Manon FRACHON | 14 Apr Tue | English
Proceeds from the financing will support the advancement of three first- and best-in-class ADC[1] programs through upcoming key clinical milestones While oncology continues to face substantial and largely unmet needs, Jeito will leverage its expertise to accelerate...
by Certifié Conforme | 8 Apr Wed | English
This record closing is the largest raise ever achieved by a fully independent European fund dedicated to Biopharma, validating Jeito’s patient-driven investment strategy, its multidisciplinary, collaborative expertise spanning from science to commercialization of...
by Manon FRACHON | 15 Oct Wed | English
Paris, France, October 15th, 2025 – Jeito Capital (“Jeito”), a leading global independent private equity fund dedicated to biopharma, today announced the promotion of Ksenija Pavletic to General Partner, reinforcing the firm’s senior leadership team as it continues to...
by Manon FRACHON | 10 Sep Wed | English
Investment will support Odyssey’s portfolio of clinical and preclinical medicines designed to precisely treat the drivers of complex autoimmune diseases. Jeito will leverage its global network, expertise and strong value creation track record in immunology and...
by Manon FRACHON | 2 Jun Mon | English
Pascal Touchon will reinforce Jeito’s expertise by bringing over 35 years of global experience in drug development, commercial activities, operational and strategic leadership at major international pharmaceutical groups and biotech companies. He will support...
Recent Comments